Manashree Damle
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Genomics and Chromatin Dynamics, Epigenetics and DNA Methylation, Pancreatic function and diabetes, Adipose Tissue and Metabolism, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Discrete functions of nuclear receptor Rev-erbα couple metabolism to the clock(2015)318 cited
- → Tumor-associated B-cells induce tumor heterogeneity and therapy resistance(2017)139 cited
- → Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion(2016)105 cited
- → Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP(2016)75 cited
- → The hepatic circadian clock fine-tunes the lipogenic response to feeding through RORα/γ(2017)73 cited
- → Identification of C2CD4A as a human diabetes susceptibility gene with a role in β cell insulin secretion(2019)70 cited
- → An HDAC3-PROX1 corepressor module acts on HNF4α to control hepatic triglycerides(2017)68 cited
- → HNF6 and Rev-erbα integrate hepatic lipid metabolism by overlapping and distinct transcriptional mechanisms(2016)65 cited
- → Targeting PPARγ in the epigenome rescues genetic metabolic defects in mice(2017)54 cited
- → Deletion of histone deacetylase 3 in adult beta cells improves glucose tolerance via increased insulin secretion(2016)53 cited